Does INOTUZUMAB OZOGAMICIN Cause Multiple organ dysfunction syndrome? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Multiple organ dysfunction syndrome have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 2.8% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
65
Reports of Multiple organ dysfunction syndrome with INOTUZUMAB OZOGAMICIN
2.8%
of all INOTUZUMAB OZOGAMICIN reports
63
Deaths
25
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From INOTUZUMAB OZOGAMICIN?
Of the 65 reports, 63 (96.9%) resulted in death, 25 (38.5%) required hospitalization, and 17 (26.2%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTUZUMAB OZOGAMICIN. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC